DekaBank Deutsche Girozentrale’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-4,000
| Closed | -$71K | – | 1241 |
|
|
2020
Q2 | $71K | Buy |
+4,000
| New | +$55.6K | ﹤0.01% | 978 |
|
|
2019
Q4 | – | Sell |
-32,500
| Closed | -$871K | – | 1262 |
|
|
2019
Q3 | $871K | Sell |
32,500
-34,500
| -51% | -$968K | 0.01% | 695 |
|
|
2019
Q2 | $1.79M | Buy |
67,000
+24,246
| +57% | +$760K | 0.01% | 654 |
|
|
2019
Q1 | $1.21M | Buy |
42,754
+6,950
| +19% | +$201K | 0.01% | 722 |
|
|
2018
Q4 | $581K | Sell |
35,804
-6,950
| -16% | -$143K | ﹤0.01% | 803 |
|
|
2018
Q3 | $1.21M | Sell |
42,754
-13,116
| -23% | -$428K | 0.01% | 735 |
|
|
2018
Q2 | $2.12M | Buy |
55,870
+29,970
| +116% | +$1.15M | 0.01% | 571 |
|
|
2018
Q1 | $830K | Sell |
25,900
-2,500
| -9% | -$110K | 0.01% | 760 |
|
|
2017
Q4 | $1.55M | Hold |
28,400
| – | – | 0.01% | 598 |
|
|
2017
Q3 | $1.55M | Hold |
28,400
| – | – | 0.01% | 606 |
|
|
2017
Q2 | $1.6M | Hold |
28,400
| – | – | 0.01% | 588 |
|
|
2017
Q1 | $1.1M | Sell |
28,400
-2,300
| -7% | -$73.3K | 0.01% | 604 |
|
|
2016
Q4 | $704K | Buy |
30,700
+2,300
| +8% | +$44.9K | 0.01% | 599 |
|
|
2016
Q3 | $644K | Hold |
28,400
| – | – | 0.01% | 622 |
|
|
2016
Q2 | $679K | Buy |
28,400
+2,100
| +8% | +$51.8K | 0.01% | 618 |
|
|
2016
Q1 | $531K | Sell |
26,300
-400
| -1% | -$12.7K | 0.01% | 646 |
|
|
2015
Q4 | $1.38M | Buy |
26,700
+500
| +2% | +$24.2K | 0.02% | 518 |
|
|
2015
Q3 | $1.12M | Buy |
26,200
+2,500
| +11% | +$121K | 0.01% | 541 |
|
|
2015
Q2 | $1.08M | Buy |
23,700
+900
| +4% | +$36.2K | 0.01% | 557 |
|
|
2015
Q1 | $865K | Sell |
22,800
-2,700
| -11% | -$92.7K | 0.01% | 595 |
|
|
2014
Q4 | $728K | Buy |
25,500
+1,300
| +5% | +$36.1K | 0.01% | 624 |
|
|
2014
Q3 | $612K | Buy |
24,200
+600
| +3% | +$15.8K | 0.01% | 607 |
|
|
2014
Q2 | $689K | Hold |
23,600
| – | – | 0.01% | 558 |
|
|
2014
Q1 | $611K | Buy |
+23,600
| New | +$630K | 0.01% | 544 |
|
DekaBank Deutsche Girozentrale's PTLA Position: Q3 2020 in Review
DekaBank Deutsche Girozentrale sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 4,000 shares — an estimated $71K sold.
DekaBank Deutsche Girozentrale first reported a position in PTLA in Q1 2014 and held it in 24 quarters. The position peaked at $2.12M in Q2 2018. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- DekaBank Deutsche Girozentrale reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- DekaBank Deutsche Girozentrale sold 4,000 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $71K.
- DekaBank Deutsche Girozentrale first reported a position in Portola Pharmaceuticals, Inc. in Q1 2014 and held it in 24 quarters.
- DekaBank Deutsche Girozentrale's Portola Pharmaceuticals, Inc. position peaked at $2.12M in Q2 2018.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2020, filed 29 Oct 2020.